Carl-Magnus Alexander Andersson

Title: Carl-Magnus Alexander Andersson: Innovator in Immunomodulating Compounds

Introduction

Carl-Magnus Alexander Andersson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with immunomodulating effects. With a total of 6 patents to his name, Andersson's work has had a meaningful impact on medical science.

Latest Patents

Among his latest patents are innovative compounds such as 3,3'-dithiobis(propionic acids) and esters thereof. This patent focuses on new 3,3'-dithiobis(propionic acids) and esters that exhibit immunomodulating effects, along with processes for their preparation, pharmaceutical compositions containing them, and methods of their pharmacological use. Another significant patent involves organic salts of N,N'-diacetyl cystine, which are new crystalline organic salts that also demonstrate immunomodulating effects, including their preparation processes and pharmaceutical applications.

Career Highlights

Throughout his career, Andersson has worked with prominent companies in the pharmaceutical industry, including Astra Aktiebolag and Aktiebolaget Astra. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug development.

Collaborations

Andersson has collaborated with notable colleagues such as Bengt Olof Sarnstrand and Bo-Goran Josefsson. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality and impact of his work.

Conclusion

Carl-Magnus Alexander Andersson is a distinguished inventor whose work in immunomodulating compounds has made a significant mark in the pharmaceutical field. His innovative patents and collaborations reflect his commitment to advancing medical science.